Oric Pharmaceuticals, Inc. (ORIC)
8.89
+1.42
(+18.93%)
USD |
NASDAQ |
Apr 02, 16:00
8.80
-0.09
(-1.01%)
After-Hours: 20:00
Oric Pharmaceuticals EPS Diluted (Quarterly) : -0.2974 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Krystal Biotech, Inc. | 1.699 |
| Olema Pharmaceuticals, Inc. | -0.5044 |
| Tango Therapeutics, Inc. | -0.2945 |
| Tyra Biosciences, Inc. | -0.5655 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.50M |
| Total Expenses (Quarterly) | 30.50M |
| Enterprise Value | 721.70M |
| Earnings Yield | -14.34% |
| Normalized Earnings Yield | -14.34 |